# Cocrystal Pharma, Inc.: Form SCHEDULE 13D/A, filed Aug 7, 2026

- Company: [Cocrystal Pharma, Inc.](/companies/cocp.md) (CIK 1412486)
- Form: SCHEDULE 13D/A
- Filed: 2026-08-07
- Accepted by EDGAR: Aug 7, 2026, 17:11 ET
- Period: not reported
- Accession: 0001493152-26-036650
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1412486/000149315226036650/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1412486/000149315226036650/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1412486/000149315226036650/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Aug 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-036650. Last ingested by Listed: Nov 6, 2026, 17:49 ET. No prices; not investment advice.